Literature DB >> 131962

Restriction of beta-adrenergic responsiveness in hypertrophied hearts of chronically isoproterenol-treated rats.

B Hein, R Hein, J Janke.   

Abstract

A single subcutaneous dose (1 mg/kg) of isoproterenol (ISO) increases the net calcium-45 uptake into the ventricular myocardium of normal rats by a factor of 3 to 4 within 6 hr. When the same dose of ISO was administered to rats previously treated with 1 mg ISO/kg per day for 1--3 weeks, this rise in labeled Ca-uptake was greatly reduced. Consequently the stimulatory effect of ISO on the Ca-dependent high-energy phosphate consumption was considerably diminished. Furthermore the chronic application of ISO produced a hypertrophy of both ventricles. When this treatment was discontinued for 7 days the ventricular weights returned to normal, whereas the restriction of beta-adrenergic reactivity persisted for more than 3 weeks. The results indicate that the decrease in responsiveness to beta-adrenergic agents is not due to the hypertrophy itself but must be considered to be an independent phenomenon-possibly resulting from adaptation to chronic beta-adrenergic overstimulation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 131962

Source DB:  PubMed          Journal:  Recent Adv Stud Cardiac Struct Metab        ISSN: 0363-5872


  3 in total

1.  Changes in myocardial pyrimidine nucleotide levels following repeated injections of isoproterenol in rats.

Authors:  A Rossi; J Olivares; J Aussedat; A Ray
Journal:  Pflugers Arch       Date:  1981-04       Impact factor: 3.657

2.  Time dependent partial loss of the effects of isoproterenol on function and energy metabolism of isolated rat hearts.

Authors:  J Giesen; M Sondermann; E Juengling; H Kammermeier
Journal:  Basic Res Cardiol       Date:  1980 Jul-Aug       Impact factor: 17.165

3.  Restriction of beta-adrenergic responsiveness in hypertrophied ventricular myocardium of rats.

Authors:  B Hein; J Janke
Journal:  Basic Res Cardiol       Date:  1977 Mar-Jun       Impact factor: 17.165

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.